DNA methylation dynamics during B cell maturation underlie a continuum of disease phenotypes in chronic lymphocytic leukemia

Christoph Plass, Christopher Oakes and colleagues study genome-wide DNA methylation dynamics during B cell maturation and the pathogenic role of transcription factor dysregulation in chronic lymphocytic leukemia (CLL). By comparing normal and malignant B cells, they find that tumors derive from a co...

Full description

Saved in:
Bibliographic Details
Published inNature genetics Vol. 48; no. 3; pp. 253 - 264
Main Authors Oakes, Christopher C, Seifert, Marc, Assenov, Yassen, Gu, Lei, Przekopowitz, Martina, Ruppert, Amy S, Wang, Qi, Imbusch, Charles D, Serva, Andrius, Koser, Sandra D, Brocks, David, Lipka, Daniel B, Bogatyrova, Olga, Weichenhan, Dieter, Brors, Benedikt, Rassenti, Laura, Kipps, Thomas J, Mertens, Daniel, Zapatka, Marc, Lichter, Peter, Döhner, Hartmut, Küppers, Ralf, Zenz, Thorsten, Stilgenbauer, Stephan, Byrd, John C, Plass, Christoph
Format Journal Article
LanguageEnglish
Published New York Nature Publishing Group US 01.03.2016
Nature Publishing Group
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Christoph Plass, Christopher Oakes and colleagues study genome-wide DNA methylation dynamics during B cell maturation and the pathogenic role of transcription factor dysregulation in chronic lymphocytic leukemia (CLL). By comparing normal and malignant B cells, they find that tumors derive from a continuum of maturation states, which correlate with different clinical outcomes. Charting differences between tumors and normal tissue is a mainstay of cancer research. However, clonal tumor expansion from complex normal tissue architectures potentially obscures cancer-specific events, including divergent epigenetic patterns. Using whole-genome bisulfite sequencing of normal B cell subsets, we observed broad epigenetic programming of selective transcription factor binding sites coincident with the degree of B cell maturation. By comparing normal B cells to malignant B cells from 268 patients with chronic lymphocytic leukemia (CLL), we showed that tumors derive largely from a continuum of maturation states reflected in normal developmental stages. Epigenetic maturation in CLL was associated with an indolent gene expression pattern and increasingly favorable clinical outcomes. We further uncovered that most previously reported tumor-specific methylation events are normally present in non-malignant B cells. Instead, we identified a potential pathogenic role for transcription factor dysregulation in CLL, where excess programming by EGR and NFAT with reduced EBF and AP-1 programming imbalances the normal B cell epigenetic program.
AbstractList Charting differences between tumors and normal tissue is a mainstay of cancer research. However, clonal tumor expansion from complex normal tissue architectures potentially obscures cancer-specific events, including divergent epigenetic patterns. Using whole-genome bisulfite sequencing of normal B cell subsets, we observed broad epigenetic programming of selective transcription factor binding sites coincident with the degree of B cell maturation. By comparing normal B cells to malignant B cells from 268 patients with chronic lymphocytic leukemia (CLL), we showed that tumors derive largely from a continuum of maturation states reflected in normal developmental stages. Epigenetic maturation in CLL was associated with an indolent gene expression pattern and increasingly favorable clinical outcomes. We further uncovered that most previously reported tumor-specific methylation events are normally present in non-malignant B cells. Instead, we identified a potential pathogenic role for transcription factor dysregulation in CLL, where excess programming by EGR and NFAT with reduced EBF and AP-1 programming imbalances the normal B cell epigenetic program.
Charting differences between tumors and normal tissue is a mainstay of cancer research. However, clonal tumor expansion from complex normal tissue architectures potentially obscures cancer-specific events, including divergent epigenetic patterns. Using whole-genome bisulfite sequencing of normal B cell subsets, we observed broad epigenetic programming of selective transcription factor binding sites coincident with the degree of B cell maturation. By comparing normal B cells to malignant B cells from 268 patients with chronic lymphocytic leukemia (CLL), we showed that tumors derive largely from a continuum of maturation states reflected in normal developmental stages. Epigenetic maturation in CLL was associated with an indolent gene expression pattern and increasingly favorable clinical outcomes. We further uncovered that most previously reported tumor-specific methylation events are normally present in non-malignant B cells. Instead, we identified a potential pathogenic role for transcription factor dysregulation in CLL, where excess programming by EGR and NFAT with reduced EBF and AP-1 programming imbalances the normal B cell epigenetic program.Charting differences between tumors and normal tissue is a mainstay of cancer research. However, clonal tumor expansion from complex normal tissue architectures potentially obscures cancer-specific events, including divergent epigenetic patterns. Using whole-genome bisulfite sequencing of normal B cell subsets, we observed broad epigenetic programming of selective transcription factor binding sites coincident with the degree of B cell maturation. By comparing normal B cells to malignant B cells from 268 patients with chronic lymphocytic leukemia (CLL), we showed that tumors derive largely from a continuum of maturation states reflected in normal developmental stages. Epigenetic maturation in CLL was associated with an indolent gene expression pattern and increasingly favorable clinical outcomes. We further uncovered that most previously reported tumor-specific methylation events are normally present in non-malignant B cells. Instead, we identified a potential pathogenic role for transcription factor dysregulation in CLL, where excess programming by EGR and NFAT with reduced EBF and AP-1 programming imbalances the normal B cell epigenetic program.
Christoph Plass, Christopher Oakes and colleagues study genome-wide DNA methylation dynamics during B cell maturation and the pathogenic role of transcription factor dysregulation in chronic lymphocytic leukemia (CLL). By comparing normal and malignant B cells, they find that tumors derive from a continuum of maturation states, which correlate with different clinical outcomes. Charting differences between tumors and normal tissue is a mainstay of cancer research. However, clonal tumor expansion from complex normal tissue architectures potentially obscures cancer-specific events, including divergent epigenetic patterns. Using whole-genome bisulfite sequencing of normal B cell subsets, we observed broad epigenetic programming of selective transcription factor binding sites coincident with the degree of B cell maturation. By comparing normal B cells to malignant B cells from 268 patients with chronic lymphocytic leukemia (CLL), we showed that tumors derive largely from a continuum of maturation states reflected in normal developmental stages. Epigenetic maturation in CLL was associated with an indolent gene expression pattern and increasingly favorable clinical outcomes. We further uncovered that most previously reported tumor-specific methylation events are normally present in non-malignant B cells. Instead, we identified a potential pathogenic role for transcription factor dysregulation in CLL, where excess programming by EGR and NFAT with reduced EBF and AP-1 programming imbalances the normal B cell epigenetic program.
Audience Academic
Author Kipps, Thomas J
Plass, Christoph
Stilgenbauer, Stephan
Byrd, John C
Döhner, Hartmut
Mertens, Daniel
Assenov, Yassen
Küppers, Ralf
Gu, Lei
Koser, Sandra D
Imbusch, Charles D
Bogatyrova, Olga
Lipka, Daniel B
Rassenti, Laura
Seifert, Marc
Weichenhan, Dieter
Ruppert, Amy S
Serva, Andrius
Zapatka, Marc
Przekopowitz, Martina
Zenz, Thorsten
Wang, Qi
Brocks, David
Lichter, Peter
Oakes, Christopher C
Brors, Benedikt
AuthorAffiliation 2 Institute of Cell Biology (Cancer Research), University of Duisburg-Essen, Essen, Germany
7 Division of Applied Bioinformatics, German Cancer Research Center (DKFZ), Heidelberg, Germany
5 Division of Hematology, Department of Internal Medicine, The Ohio State University, Columbus, Ohio, USA
10 Cooperation Unit Mechanisms of Leukemogenesis, German Cancer Research Center (DKFZ), Heidelberg, Germany
8 Division of Molecular Genetics, German Cancer Research Center (DKFZ), Heidelberg, Germany
1 Division of Epigenomics and Cancer Risk Factors, German Cancer Research Center (DKFZ), Heidelberg, Germany
4 Division of Newborn Medicine, Boston Children’s Hospital, Boston, Massachusetts, USA
6 Division of Theoretical Bioinformatics, German Cancer Research Center (DKFZ), Heidelberg, Germany
11 Department of Internal Medicine III, University of Ulm, Ulm, Germany
3 Department of Cell Biology, Harvard Medical School, Boston, Massachusetts, USA
9 Department of Medicine, University of California at San Diego Moo
AuthorAffiliation_xml – name: 3 Department of Cell Biology, Harvard Medical School, Boston, Massachusetts, USA
– name: 11 Department of Internal Medicine III, University of Ulm, Ulm, Germany
– name: 1 Division of Epigenomics and Cancer Risk Factors, German Cancer Research Center (DKFZ), Heidelberg, Germany
– name: 7 Division of Applied Bioinformatics, German Cancer Research Center (DKFZ), Heidelberg, Germany
– name: 10 Cooperation Unit Mechanisms of Leukemogenesis, German Cancer Research Center (DKFZ), Heidelberg, Germany
– name: 4 Division of Newborn Medicine, Boston Children’s Hospital, Boston, Massachusetts, USA
– name: 13 Department of Medicine V, University of Heidelberg, Heidelberg, Germany
– name: 5 Division of Hematology, Department of Internal Medicine, The Ohio State University, Columbus, Ohio, USA
– name: 8 Division of Molecular Genetics, German Cancer Research Center (DKFZ), Heidelberg, Germany
– name: 12 Department of Translational Oncology, National Center for Tumor Diseases (NCT) and German Cancer Research Center (DKFZ), Heidelberg, Germany
– name: 2 Institute of Cell Biology (Cancer Research), University of Duisburg-Essen, Essen, Germany
– name: 6 Division of Theoretical Bioinformatics, German Cancer Research Center (DKFZ), Heidelberg, Germany
– name: 9 Department of Medicine, University of California at San Diego Moores Cancer Center, La Jolla, California, USA
Author_xml – sequence: 1
  givenname: Christopher C
  surname: Oakes
  fullname: Oakes, Christopher C
  email: christopher.oakes@osumc.edu
  organization: Division of Epigenomics and Cancer Risk Factors, German Cancer Research Center (DKFZ), Present address: Division of Hematology, Department of Internal Medicine, The Ohio State University, Columbus, Ohio, USA
– sequence: 2
  givenname: Marc
  surname: Seifert
  fullname: Seifert, Marc
  organization: Institute of Cell Biology (Cancer Research), University of Duisburg-Essen
– sequence: 3
  givenname: Yassen
  surname: Assenov
  fullname: Assenov, Yassen
  organization: Division of Epigenomics and Cancer Risk Factors, German Cancer Research Center (DKFZ)
– sequence: 4
  givenname: Lei
  surname: Gu
  fullname: Gu, Lei
  organization: Department of Cell Biology, Harvard Medical School, Division of Newborn Medicine, Boston Children's Hospital
– sequence: 5
  givenname: Martina
  surname: Przekopowitz
  fullname: Przekopowitz, Martina
  organization: Institute of Cell Biology (Cancer Research), University of Duisburg-Essen
– sequence: 6
  givenname: Amy S
  surname: Ruppert
  fullname: Ruppert, Amy S
  organization: Division of Hematology, Department of Internal Medicine, The Ohio State University
– sequence: 7
  givenname: Qi
  surname: Wang
  fullname: Wang, Qi
  organization: Division of Theoretical Bioinformatics, German Cancer Research Center (DKFZ), Division of Applied Bioinformatics, German Cancer Research Center (DKFZ)
– sequence: 8
  givenname: Charles D
  surname: Imbusch
  fullname: Imbusch, Charles D
  organization: Division of Theoretical Bioinformatics, German Cancer Research Center (DKFZ), Division of Applied Bioinformatics, German Cancer Research Center (DKFZ)
– sequence: 9
  givenname: Andrius
  surname: Serva
  fullname: Serva, Andrius
  organization: Division of Molecular Genetics, German Cancer Research Center (DKFZ)
– sequence: 10
  givenname: Sandra D
  surname: Koser
  fullname: Koser, Sandra D
  organization: Division of Theoretical Bioinformatics, German Cancer Research Center (DKFZ), Division of Applied Bioinformatics, German Cancer Research Center (DKFZ)
– sequence: 11
  givenname: David
  surname: Brocks
  fullname: Brocks, David
  organization: Division of Epigenomics and Cancer Risk Factors, German Cancer Research Center (DKFZ)
– sequence: 12
  givenname: Daniel B
  surname: Lipka
  fullname: Lipka, Daniel B
  organization: Division of Epigenomics and Cancer Risk Factors, German Cancer Research Center (DKFZ)
– sequence: 13
  givenname: Olga
  surname: Bogatyrova
  fullname: Bogatyrova, Olga
  organization: Division of Epigenomics and Cancer Risk Factors, German Cancer Research Center (DKFZ)
– sequence: 14
  givenname: Dieter
  surname: Weichenhan
  fullname: Weichenhan, Dieter
  organization: Division of Epigenomics and Cancer Risk Factors, German Cancer Research Center (DKFZ)
– sequence: 15
  givenname: Benedikt
  surname: Brors
  fullname: Brors, Benedikt
  organization: Division of Theoretical Bioinformatics, German Cancer Research Center (DKFZ), Division of Applied Bioinformatics, German Cancer Research Center (DKFZ)
– sequence: 16
  givenname: Laura
  surname: Rassenti
  fullname: Rassenti, Laura
  organization: Department of Medicine, University of California at San Diego Moores Cancer Center
– sequence: 17
  givenname: Thomas J
  surname: Kipps
  fullname: Kipps, Thomas J
  organization: Department of Medicine, University of California at San Diego Moores Cancer Center
– sequence: 18
  givenname: Daniel
  surname: Mertens
  fullname: Mertens, Daniel
  organization: Cooperation Unit Mechanisms of Leukemogenesis, German Cancer Research Center (DKFZ), Department of Internal Medicine III, University of Ulm
– sequence: 19
  givenname: Marc
  surname: Zapatka
  fullname: Zapatka, Marc
  organization: Division of Molecular Genetics, German Cancer Research Center (DKFZ)
– sequence: 20
  givenname: Peter
  surname: Lichter
  fullname: Lichter, Peter
  organization: Division of Molecular Genetics, German Cancer Research Center (DKFZ), Present address: Division of Hematology, Department of Internal Medicine, The Ohio State University, Columbus, Ohio, USA
– sequence: 21
  givenname: Hartmut
  surname: Döhner
  fullname: Döhner, Hartmut
  organization: Department of Internal Medicine III, University of Ulm
– sequence: 22
  givenname: Ralf
  surname: Küppers
  fullname: Küppers, Ralf
  organization: Institute of Cell Biology (Cancer Research), University of Duisburg-Essen
– sequence: 23
  givenname: Thorsten
  surname: Zenz
  fullname: Zenz, Thorsten
  organization: Department of Translational Oncology, National Center for Tumor Diseases (NCT) and German Cancer Research Center (DKFZ), Department of Medicine V, University of Heidelberg
– sequence: 24
  givenname: Stephan
  surname: Stilgenbauer
  fullname: Stilgenbauer, Stephan
  organization: Cooperation Unit Mechanisms of Leukemogenesis, German Cancer Research Center (DKFZ)
– sequence: 25
  givenname: John C
  surname: Byrd
  fullname: Byrd, John C
  organization: Division of Hematology, Department of Internal Medicine, The Ohio State University
– sequence: 26
  givenname: Christoph
  orcidid: 0000-0003-2554-3952
  surname: Plass
  fullname: Plass, Christoph
  email: c.plass@dkfz.de
  organization: Division of Epigenomics and Cancer Risk Factors, German Cancer Research Center (DKFZ)
BackLink https://www.ncbi.nlm.nih.gov/pubmed/26780610$$D View this record in MEDLINE/PubMed
BookMark eNqNkl2L1DAUhousuB-K_0ACXqgXHZNN0mZuhHH9Wlhc8Os2pOlpJ2ub1CQVC_54U2dWd0ZBCSQh58nL4T3vcXZgnYUsu0_wgmAqntp2QZkQt7IjwlmRk5KIg3THBckZpsVhdhzCFcaEMSzuZIenRSlSDR9l31-8XaEe4nrqVDTOonqyqjc6oHr0xrboOdLQdahXcfQbYrQ1-M4AUkg7G40dxx65BtUmgAqAhjVYF6cBAjIW6bV31mjUTf2wdnqK8x3Gz9AbdTe73aguwL3teZJ9fPXyw9mb_OLy9fnZ6iLXJWUx7Urx5rRiBSesJrTSpNJcY1U3tKkElJWiitZ8iVnNOaUUU0oYL3GheSlgSU-yZxvdYax6qDXY6FUnB2965SfplJG7FWvWsnVfJVsWFGOeBB5vBbz7MkKIsjdh9kVZcGOQRGBRMkyW9N9oWQhSlASzhD7cQ6_c6G1yIlFlGuuScfqbalUH0tjGpRb1LCpXjBVEsJKRRC3-QqVVJ6PTmKAx6X3nw5OdD_Mo4Vts1RiCPH__7v_Zy0-77IObXv8y-TpyCcg3gPYuBA-N1Cb-TFbq2HSSYDlHWtpWzpFO_KM9_lryT3JrfRjm6IK_4ece-gOQUgGI
CitedBy_id crossref_primary_10_1182_bloodadvances_2024013327
crossref_primary_10_1007_s10528_018_9841_1
crossref_primary_10_1002_ajh_26367
crossref_primary_10_1080_10428194_2024_2438804
crossref_primary_10_1371_journal_pone_0208753
crossref_primary_10_15252_msb_20178124
crossref_primary_10_3389_fonc_2019_00079
crossref_primary_10_1158_2643_3230_BCD_20_0207
crossref_primary_10_15252_embr_202256420
crossref_primary_10_1172_JCI93801
crossref_primary_10_1007_s13205_024_04133_0
crossref_primary_10_3324_haematol_2021_278477
crossref_primary_10_1016_j_celrep_2019_10_106
crossref_primary_10_1038_s41392_023_01528_y
crossref_primary_10_3390_biomedicines11092335
crossref_primary_10_6004_jnccn_2020_7623
crossref_primary_10_1038_s41586_019_1198_z
crossref_primary_10_1126_sciimmunol_aau7523
crossref_primary_10_1080_14728222_2017_1370454
crossref_primary_10_1093_nargab_lqae181
crossref_primary_10_1111_imr_12733
crossref_primary_10_3389_fbioe_2022_842019
crossref_primary_10_1155_2020_7084268
crossref_primary_10_1182_hematology_2019000367
crossref_primary_10_1007_s12032_022_01737_5
crossref_primary_10_1016_j_ccell_2016_03_009
crossref_primary_10_1101_gr_269233_120
crossref_primary_10_1126_scitranslmed_abc4834
crossref_primary_10_1002_art_40877
crossref_primary_10_1002_gcc_22687
crossref_primary_10_1186_s13293_018_0213_7
crossref_primary_10_1186_s12935_021_02266_3
crossref_primary_10_2217_epi_2016_0064
crossref_primary_10_18632_oncotarget_27080
crossref_primary_10_1186_s13073_020_00724_7
crossref_primary_10_1158_2159_8290_CD_20_1202
crossref_primary_10_52547_rbmb_10_3_455
crossref_primary_10_1016_j_coi_2020_09_004
crossref_primary_10_1080_15592294_2020_1834921
crossref_primary_10_1111_bph_13949
crossref_primary_10_1053_j_seminhematol_2023_11_005
crossref_primary_10_1111_bjh_15757
crossref_primary_10_1038_s43018_020_00132_1
crossref_primary_10_1002_ijc_31057
crossref_primary_10_29296_24999490_2024_06_03
crossref_primary_10_1038_s41467_022_29450_x
crossref_primary_10_1093_nargab_lqab121
crossref_primary_10_1111_bjh_18465
crossref_primary_10_1002_ajh_27546
crossref_primary_10_3390_diagnostics11050853
crossref_primary_10_1186_s13148_016_0274_6
crossref_primary_10_1016_j_semcancer_2017_09_008
crossref_primary_10_1007_s00438_016_1264_2
crossref_primary_10_3389_fimmu_2018_02720
crossref_primary_10_1158_1535_7163_MCT_15_0685
crossref_primary_10_1158_2159_8290_CD_20_1334
crossref_primary_10_1371_journal_pcbi_1009323
crossref_primary_10_1038_s41591_018_0028_4
crossref_primary_10_1038_s41416_020_01117_8
crossref_primary_10_3892_ol_2024_14685
crossref_primary_10_2217_epi_2018_0020
crossref_primary_10_1146_annurev_pathmechdis_051122_100856
crossref_primary_10_1158_2643_3230_BCD_21_0098
crossref_primary_10_1093_bioinformatics_bty644
crossref_primary_10_1101_cshperspect_a035220
crossref_primary_10_3389_fonc_2021_790004
crossref_primary_10_1089_omi_2018_0206
crossref_primary_10_1016_j_ccell_2016_09_014
crossref_primary_10_1182_blood_2020010029
crossref_primary_10_3390_epigenomes6030028
crossref_primary_10_1038_s41467_022_30050_y
crossref_primary_10_3390_cancers12030629
crossref_primary_10_1002_ajh_24301
crossref_primary_10_1159_000487868
crossref_primary_10_1101_cshperspect_a026740
crossref_primary_10_1016_j_semcancer_2017_08_008
crossref_primary_10_1016_j_semcancer_2020_08_004
crossref_primary_10_1182_blood_2015_12_687814
crossref_primary_10_1002_ijc_31999
crossref_primary_10_1038_s41388_020_01549_9
crossref_primary_10_1182_blood_2020010036
crossref_primary_10_1182_bloodadvances_2018024059
crossref_primary_10_1016_j_coi_2018_09_020
crossref_primary_10_1016_j_ebiom_2021_103559
crossref_primary_10_3389_fimmu_2020_01766
crossref_primary_10_3389_fonc_2023_1146486
crossref_primary_10_1016_j_beha_2016_09_003
crossref_primary_10_1016_j_bneo_2024_100059
crossref_primary_10_1111_imm_13207
crossref_primary_10_1182_blood_2022015854
crossref_primary_10_3389_fonc_2023_1248964
crossref_primary_10_1038_s43018_021_00216_6
crossref_primary_10_37349_etat_2024_00253
crossref_primary_10_1038_s41598_020_66224_1
crossref_primary_10_1016_j_smim_2019_101323
crossref_primary_10_1002_hon_2725
crossref_primary_10_1080_15592294_2022_2050004
crossref_primary_10_3324_haematol_2020_251561
crossref_primary_10_1182_blood_2023023797
crossref_primary_10_1186_s12864_017_4117_4
crossref_primary_10_1016_j_biochi_2024_07_006
crossref_primary_10_3390_cancers14030830
crossref_primary_10_1038_nrg_2016_93
crossref_primary_10_3892_ol_2017_5725
crossref_primary_10_1038_s41388_021_01923_1
crossref_primary_10_15252_msb_202110855
crossref_primary_10_1111_imr_13045
crossref_primary_10_3390_cells12192392
crossref_primary_10_1371_journal_pone_0185940
crossref_primary_10_56875_2589_0646_1117
crossref_primary_10_1002_path_6410
crossref_primary_10_1093_hmg_ddy094
crossref_primary_10_1007_s00438_017_1298_0
crossref_primary_10_3390_cancers16061095
crossref_primary_10_15252_msb_20188339
crossref_primary_10_1158_1078_0432_CCR_20_3184
crossref_primary_10_1016_j_biopha_2017_12_059
crossref_primary_10_1038_s41467_018_03025_1
crossref_primary_10_1182_blood_2016_03_707786
crossref_primary_10_1016_j_molimm_2017_11_014
crossref_primary_10_1182_bloodadvances_2019000817
crossref_primary_10_1016_S2152_2650_21_01241_6
crossref_primary_10_1016_j_beha_2023_101513
crossref_primary_10_3324_haematol_2019_236000
crossref_primary_10_3389_fgene_2022_1056043
crossref_primary_10_1002_ijc_30905
crossref_primary_10_1182_blood_2020008311
crossref_primary_10_3390_ijms22179337
crossref_primary_10_1038_leu_2016_359
crossref_primary_10_3390_genes7120125
crossref_primary_10_1186_s13148_019_0783_1
crossref_primary_10_1097_HS9_0000000000000334
crossref_primary_10_1177_11772719211067972
crossref_primary_10_7554_eLife_73754
crossref_primary_10_1038_s41525_017_0010_y
crossref_primary_10_1038_s41598_020_57919_6
crossref_primary_10_1016_j_semcancer_2018_02_001
crossref_primary_10_1080_10428194_2022_2153359
crossref_primary_10_1186_s13045_021_01032_2
crossref_primary_10_1146_annurev_pathmechdis_012419_032810
crossref_primary_10_3390_cancers13143587
crossref_primary_10_1038_s41588_022_01140_w
crossref_primary_10_3390_epigenomes8030032
crossref_primary_10_1038_s41467_021_25403_y
crossref_primary_10_1111_bjh_14719
crossref_primary_10_1016_j_mrfmmm_2017_11_001
crossref_primary_10_1093_nar_gkab322
crossref_primary_10_1186_s43042_023_00411_3
crossref_primary_10_1038_s41556_023_01114_y
crossref_primary_10_1038_nm_4410
crossref_primary_10_15252_emmm_201607180
crossref_primary_10_1200_JCO_2016_71_0822
crossref_primary_10_1534_g3_117_300446
crossref_primary_10_3324_haematol_2019_240721
crossref_primary_10_3324_haematol_2022_281869
crossref_primary_10_1182_blood_2019000490
crossref_primary_10_1182_blood_2017_10_764373
crossref_primary_10_1038_s41467_021_26400_x
crossref_primary_10_1007_s11912_019_0819_x
crossref_primary_10_1182_blood_2018_11_844688
crossref_primary_10_1158_2643_3230_BCD_19_0058
crossref_primary_10_1016_j_jid_2019_05_011
crossref_primary_10_1007_s40142_019_00178_3
crossref_primary_10_3389_fonc_2022_897280
crossref_primary_10_1016_j_jid_2016_11_029
crossref_primary_10_1038_leu_2017_177
crossref_primary_10_1016_j_hoc_2021_03_002
crossref_primary_10_1016_j_hoc_2021_03_004
crossref_primary_10_1182_blood_2018_02_692970
crossref_primary_10_3389_fimmu_2023_1308378
crossref_primary_10_1111_joim_13423
crossref_primary_10_1016_j_sjbs_2017_11_036
crossref_primary_10_1093_hmg_ddaa147
crossref_primary_10_1186_s13073_021_00837_7
crossref_primary_10_1038_s41467_022_32052_2
crossref_primary_10_1182_blood_2018_03_842088
crossref_primary_10_1038_s41467_022_29625_6
crossref_primary_10_1007_s00438_016_1254_4
crossref_primary_10_1186_s12943_025_02260_7
crossref_primary_10_1080_08830185_2021_1964498
crossref_primary_10_1093_bioinformatics_btz327
crossref_primary_10_1038_s41375_020_0846_5
crossref_primary_10_1074_mcp_RA117_000539
crossref_primary_10_1038_ncomms14175
crossref_primary_10_1038_s43018_020_00131_2
crossref_primary_10_1172_JCI138833
crossref_primary_10_1038_s41467_019_14081_6
crossref_primary_10_1002_gcc_22672
crossref_primary_10_1186_s12859_020_3455_4
crossref_primary_10_1182_blood_2018_09_835389
crossref_primary_10_3389_fonc_2023_1143811
crossref_primary_10_3389_fimmu_2018_00683
crossref_primary_10_3390_genes11010110
crossref_primary_10_1038_s41467_017_02177_w
crossref_primary_10_1039_C6CS00599C
crossref_primary_10_1038_s41467_020_20849_y
crossref_primary_10_1038_nrdp_2016_96
crossref_primary_10_1038_s41576_024_00760_8
crossref_primary_10_1186_s13072_018_0252_7
crossref_primary_10_1038_s41598_022_19087_7
crossref_primary_10_1101_gr_277298_122
crossref_primary_10_20517_cdr_2023_98
crossref_primary_10_3389_fonc_2021_651057
crossref_primary_10_1038_leu_2016_230
crossref_primary_10_1111_febs_14934
crossref_primary_10_1038_leu_2016_356
crossref_primary_10_1038_leu_2016_226
crossref_primary_10_1016_j_ccell_2018_11_013
crossref_primary_10_1111_bjh_17193
crossref_primary_10_1038_s41467_022_34642_6
crossref_primary_10_1038_s41467_022_33385_8
crossref_primary_10_1182_blood_2023022180
crossref_primary_10_1182_bloodadvances_2019000367
crossref_primary_10_1016_j_molmed_2021_07_012
crossref_primary_10_1038_nrc_2017_121
crossref_primary_10_18632_oncotarget_20081
crossref_primary_10_3390_cancers14030663
crossref_primary_10_1155_2024_1370364
crossref_primary_10_1038_leu_2016_10
crossref_primary_10_1016_j_ccell_2018_11_001
crossref_primary_10_1080_10428194_2024_2341151
crossref_primary_10_1182_bloodadvances_2019000237
crossref_primary_10_1038_s41467_019_09645_5
crossref_primary_10_1097_HS9_0000000000000959
Cites_doi 10.1084/jem.194.11.1625
10.1182/blood-2012-01-402453
10.1182/blood-2010-05-284984
10.1038/nprot.2013.118
10.1038/ng.3413
10.1089/106652702761034136
10.1182/blood.V100.4.1410.h81602001410_1410_1416
10.1038/leu.2012.280
10.1111/j.1365-2141.2010.08299.x
10.1038/nature09906
10.1158/2159-8290.CD-13-0349
10.1182/blood-2014-02-555722
10.2217/epi.11.73
10.1038/nrc3486
10.1016/j.semcancer.2010.09.004
10.1016/j.ccell.2014.10.012
10.1182/blood-2011-06-357996
10.1038/nmeth.3115
10.1016/j.celrep.2014.06.053
10.1126/science.1242510
10.1038/ng.2443
10.1073/pnas.0810965105
10.1038/nature10113
10.1038/nature14192
10.1101/gr.103606.109
10.4049/jimmunol.181.5.3364
10.1038/bcj.2015.14
10.1016/0092-8674(94)90076-0
10.1016/j.stem.2014.07.005
10.1084/jem.188.9.1679
10.1182/blood-2006-11-056648
10.1093/bioinformatics/btp698
10.1084/jem.20101947
10.1038/nbt.1630
10.1038/nature12433
10.1016/S1074-7613(01)00085-1
10.1084/jem.20120833
10.1093/nar/gkt1323
10.1182/blood-2012-04-423517
10.1158/2159-8290.CD-14-0104
10.1182/blood-2006-12-062265
10.1016/S1074-7613(00)80040-0
10.1084/jem.185.3.563
10.1016/j.ccr.2012.08.024
10.1101/gr.155473.113
10.1038/leu.2014.252
10.4049/jimmunol.181.7.4590
10.1038/nature12787
10.1126/science.1256271
10.1016/j.exphem.2014.04.012
10.1016/j.cell.2013.01.019
10.1101/gr.152132.112
10.2217/epi.09.14
10.1073/pnas.1413374111
10.1038/leu.2012.245
10.1038/ng.3291
10.1093/bioinformatics/bts680
10.1073/pnas.0506580102
10.1126/science.1105136
10.1038/nrg3354
ContentType Journal Article
Copyright Springer Nature America, Inc. 2015
COPYRIGHT 2016 Nature Publishing Group
Copyright Nature Publishing Group Mar 2016
Copyright_xml – notice: Springer Nature America, Inc. 2015
– notice: COPYRIGHT 2016 Nature Publishing Group
– notice: Copyright Nature Publishing Group Mar 2016
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
IOV
ISR
3V.
7QL
7QP
7QR
7SS
7T7
7TK
7TM
7U9
7X7
7XB
88A
88E
8AO
8C1
8FD
8FE
8FH
8FI
8FJ
8FK
8G5
ABUWG
AEUYN
AFKRA
AZQEC
BBNVY
BENPR
BHPHI
C1K
CCPQU
DWQXO
FR3
FYUFA
GHDGH
GNUQQ
GUQSH
H94
HCIFZ
K9.
LK8
M0S
M1P
M2O
M7N
M7P
MBDVC
P64
PHGZM
PHGZT
PJZUB
PKEHL
PPXIY
PQEST
PQGLB
PQQKQ
PQUKI
PRINS
Q9U
RC3
7X8
7T5
5PM
DOI 10.1038/ng.3488
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
Opposing Viewpoints In Context
Gale In Context: Science
ProQuest Central (Corporate)
Bacteriology Abstracts (Microbiology B)
Calcium & Calcified Tissue Abstracts
Chemoreception Abstracts
Entomology Abstracts (Full archive)
Industrial and Applied Microbiology Abstracts (Microbiology A)
Neurosciences Abstracts
Nucleic Acids Abstracts
Virology and AIDS Abstracts
Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Biology Database (Alumni Edition)
Medical Database (Alumni Edition)
ProQuest Pharma Collection
Public Health Database
Technology Research Database
ProQuest SciTech Collection
ProQuest Natural Science Collection
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Research Library
ProQuest Central (Alumni)
ProQuest One Sustainability
ProQuest Central UK/Ireland
ProQuest Central Essentials
Biological Science Collection
ProQuest Central
Natural Science Collection
Environmental Sciences and Pollution Management
ProQuest One Community College
ProQuest Central Korea
Engineering Research Database
Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Central Student
Research Library Prep
AIDS and Cancer Research Abstracts
SciTech Premium Collection
ProQuest Health & Medical Complete (Alumni)
Biological Sciences
ProQuest Health & Medical Collection
Medical Database
Research Library
Algology Mycology and Protozoology Abstracts (Microbiology C)
Biological Science Database
Research Library (Corporate)
Biotechnology and BioEngineering Abstracts
ProQuest Central Premium
ProQuest One Academic
ProQuest Health & Medical Research Collection
ProQuest One Academic Middle East (New)
ProQuest One Health & Nursing
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Applied & Life Sciences
ProQuest One Academic
ProQuest One Academic UKI Edition
ProQuest Central China
ProQuest Central Basic
Genetics Abstracts
MEDLINE - Academic
Immunology Abstracts
PubMed Central (Full Participant titles)
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
Research Library Prep
ProQuest Central Student
ProQuest Central Essentials
Nucleic Acids Abstracts
SciTech Premium Collection
ProQuest Central China
Environmental Sciences and Pollution Management
ProQuest One Applied & Life Sciences
ProQuest One Sustainability
Health Research Premium Collection
Natural Science Collection
Health & Medical Research Collection
Biological Science Collection
Chemoreception Abstracts
Industrial and Applied Microbiology Abstracts (Microbiology A)
ProQuest Central (New)
ProQuest Medical Library (Alumni)
Virology and AIDS Abstracts
ProQuest Biological Science Collection
ProQuest One Academic Eastern Edition
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
Biological Science Database
Neurosciences Abstracts
ProQuest Hospital Collection (Alumni)
Biotechnology and BioEngineering Abstracts
Entomology Abstracts
ProQuest Health & Medical Complete
ProQuest One Academic UKI Edition
Engineering Research Database
ProQuest One Academic
Calcium & Calcified Tissue Abstracts
ProQuest One Academic (New)
Technology Research Database
ProQuest One Academic Middle East (New)
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
ProQuest One Community College
ProQuest One Health & Nursing
Research Library (Alumni Edition)
ProQuest Natural Science Collection
ProQuest Pharma Collection
ProQuest Biology Journals (Alumni Edition)
ProQuest Central
ProQuest Health & Medical Research Collection
Genetics Abstracts
Health and Medicine Complete (Alumni Edition)
ProQuest Central Korea
Bacteriology Abstracts (Microbiology B)
Algology Mycology and Protozoology Abstracts (Microbiology C)
AIDS and Cancer Research Abstracts
ProQuest Research Library
ProQuest Public Health
ProQuest Central Basic
ProQuest SciTech Collection
ProQuest Medical Library
ProQuest Central (Alumni)
MEDLINE - Academic
Immunology Abstracts
DatabaseTitleList Genetics Abstracts
Research Library Prep
MEDLINE - Academic



MEDLINE
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
– sequence: 3
  dbid: BENPR
  name: ProQuest Central
  url: https://www.proquest.com/central
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Agriculture
Biology
EISSN 1546-1718
EndPage 264
ExternalDocumentID PMC4963005
3970892311
A446184741
26780610
10_1038_ng_3488
Genre Research Support, Non-U.S. Gov't
Journal Article
Research Support, N.I.H., Extramural
Feature
GrantInformation_xml – fundername: NCI NIH HHS
  grantid: P01 CA081534
– fundername: NCI NIH HHS
  grantid: P01-CA81534
GroupedDBID ---
-DZ
-~X
.55
.GJ
0R~
123
29M
2FS
36B
39C
3O-
3V.
4.4
53G
5BI
5M7
5RE
5S5
70F
7X7
85S
88A
88E
8AO
8C1
8FE
8FH
8FI
8FJ
8G5
8R4
8R5
AAEEF
AAHBH
AARCD
AAYOK
AAYZH
AAZLF
ABAWZ
ABCQX
ABDBF
ABDPE
ABEFU
ABJNI
ABLJU
ABOCM
ABTAH
ABUWG
ACBWK
ACGFO
ACGFS
ACIWK
ACMJI
ACNCT
ACPRK
ACUHS
ADBBV
ADFRT
AENEX
AEUYN
AFBBN
AFFNX
AFKRA
AFRAH
AFSHS
AGAYW
AGCDD
AGHTU
AHBCP
AHMBA
AHOSX
AHSBF
AIBTJ
ALFFA
ALIPV
ALMA_UNASSIGNED_HOLDINGS
AMTXH
ARMCB
ASPBG
AVWKF
AXYYD
AZFZN
AZQEC
B0M
BBNVY
BENPR
BHPHI
BKKNO
BPHCQ
BVXVI
CCPQU
CS3
DB5
DU5
DWQXO
EAD
EAP
EBC
EBD
EBS
EE.
EJD
EMB
EMK
EMOBN
EPL
ESX
EXGXG
F5P
FEDTE
FQGFK
FSGXE
FYUFA
GNUQQ
GUQSH
GX1
HCIFZ
HMCUK
HVGLF
HZ~
IAO
IH2
IHR
INH
INR
IOV
ISR
ITC
L7B
LGEZI
LK8
LOTEE
M0L
M1P
M2O
M7P
MVM
N9A
NADUK
NNMJJ
NXXTH
ODYON
P2P
PKN
PQQKQ
PROAC
PSQYO
Q2X
RIG
RNS
RNT
RNTTT
RVV
SHXYY
SIXXV
SJN
SNYQT
SOJ
SV3
TAOOD
TBHMF
TDRGL
TN5
TSG
TUS
UKHRP
VQA
X7M
XJT
XOL
Y6R
YHZ
ZGI
ZXP
ZY4
~8M
~KM
AAYXX
ABFSG
ACMFV
ACSTC
AETEA
AFANA
ALPWD
ATHPR
CITATION
PHGZM
PHGZT
CGR
CUY
CVF
ECM
EIF
NFIDA
NPM
AEIIB
PMFND
7QL
7QP
7QR
7SS
7T7
7TK
7TM
7U9
7XB
8FD
8FK
C1K
FR3
H94
K9.
M7N
MBDVC
P64
PJZUB
PKEHL
PPXIY
PQEST
PQGLB
PQUKI
PRINS
Q9U
RC3
7X8
7T5
5PM
ID FETCH-LOGICAL-c734t-c7aa5f2b46514d13bc1bc5c0adf3fb8e7ba3a3d5904d55333033145706c578e93
IEDL.DBID 7X7
ISSN 1061-4036
1546-1718
IngestDate Thu Aug 21 18:07:08 EDT 2025
Fri Jul 11 03:40:04 EDT 2025
Thu Jul 10 21:57:00 EDT 2025
Fri Jul 25 09:04:17 EDT 2025
Tue Jun 17 20:48:42 EDT 2025
Tue Jun 10 20:34:47 EDT 2025
Fri Jun 27 03:31:49 EDT 2025
Fri Jun 27 04:04:08 EDT 2025
Thu Apr 03 07:11:19 EDT 2025
Thu Apr 24 23:06:45 EDT 2025
Tue Jul 01 01:50:13 EDT 2025
Fri Feb 21 02:39:09 EST 2025
IsDoiOpenAccess false
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 3
Language English
License Reprints and permissions information is available online at http://www.nature.com/reprints/index.html.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c734t-c7aa5f2b46514d13bc1bc5c0adf3fb8e7ba3a3d5904d55333033145706c578e93
Notes SourceType-Scholarly Journals-1
ObjectType-Feature-1
content type line 14
ObjectType-Article-1
ObjectType-Feature-2
content type line 23
Present address: Division of Hematology, Department of Internal Medicine, The Ohio State University, Columbus, Ohio, USA.
ORCID 0000-0003-2554-3952
OpenAccessLink http://doi.org/10.1038/ng.3488
PMID 26780610
PQID 1770389453
PQPubID 33429
PageCount 12
ParticipantIDs pubmedcentral_primary_oai_pubmedcentral_nih_gov_4963005
proquest_miscellaneous_1808740193
proquest_miscellaneous_1768167104
proquest_journals_1770389453
gale_infotracmisc_A446184741
gale_infotracacademiconefile_A446184741
gale_incontextgauss_ISR_A446184741
gale_incontextgauss_IOV_A446184741
pubmed_primary_26780610
crossref_citationtrail_10_1038_ng_3488
crossref_primary_10_1038_ng_3488
springer_journals_10_1038_ng_3488
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2016-03-01
PublicationDateYYYYMMDD 2016-03-01
PublicationDate_xml – month: 03
  year: 2016
  text: 2016-03-01
  day: 01
PublicationDecade 2010
PublicationPlace New York
PublicationPlace_xml – name: New York
– name: United States
PublicationTitle Nature genetics
PublicationTitleAbbrev Nat Genet
PublicationTitleAlternate Nat Genet
PublicationYear 2016
Publisher Nature Publishing Group US
Nature Publishing Group
Publisher_xml – name: Nature Publishing Group US
– name: Nature Publishing Group
References Ernst (CR20) 2011; 473
Ferreira (CR29) 2014; 24
Kröber (CR51) 2002; 100
Kasowski (CR5) 2013; 342
Wang (CR17) 2013; 8
Klein (CR39) 2001; 194
Ziller (CR3) 2013; 500
Cabezas-Wallscheid (CR7) 2014; 15
Sturm (CR36) 2012; 22
Bibikova (CR53) 2009; 1
Bohle, Döring, Hansmann, Küppers (CR60) 2013; 27
Kretzmer (CR43) 2015; 47
Li, Durbin (CR52) 2010; 26
Florean, Schnekenburger, Grandjenette, Dicato, Diederich (CR22) 2011; 3
Rosén, Murray, Evaldsson, Rosenquist (CR49) 2010; 20
Pekarsky (CR50) 2008; 105
Teschendorff (CR55) 2013; 29
Andersson (CR1) 2014; 507
Lara-Astiaso (CR6) 2014; 345
Peng, Gerth, Ranger, Glimcher (CR46) 2001; 14
Kulis (CR15) 2015; 47
CR2
Shaknovich (CR18) 2011; 118
Cahill (CR12) 2013; 27
Queiros (CR11) 2015; 29
Puente (CR30) 2011; 475
Timp, Feinberg (CR9) 2013; 13
Landau (CR14) 2014; 26
Lai (CR19) 2013; 23
Schübeler (CR8) 2015; 517
Desper, Gascuel (CR58) 2002; 9
Oakes (CR13) 2014; 4
Pham (CR37) 2012; 119
Seifert (CR28) 2012; 209
Assenov (CR56) 2014; 11
Gustems (CR48) 2014; 42
Zhuang, Soriano, Weintraub (CR44) 1994; 79
Chen (CR41) 2008; 111
Kulis (CR10) 2012; 44
Reindl (CR34) 2010; 151
Zandi (CR26) 2008; 181
Klein, Rajewsky, Küppers (CR40) 1998; 188
Herishanu (CR32) 2011; 117
Landau (CR31) 2013; 152
Brocks (CR57) 2014; 8
Edelmann (CR35) 2012; 120
Heltemes-Harris (CR27) 2011; 208
Gururajan (CR45) 2008; 181
CR54
Smith, Meissner (CR4) 2013; 14
Mockridge (CR33) 2007; 109
Claus (CR25) 2014; 124
Dvinge (CR21) 2014; 111
Prange, Singh, Martens (CR42) 2014; 42
Teschendorff (CR23) 2010; 20
Smith (CR24) 2015; 5
McLean (CR61) 2010; 28
Subramanian (CR59) 2005; 102
Garrett-Sinha (CR47) 1999; 10
Damm (CR38) 2014; 4
Lebecque, de Bouteiller, Arpin, Banchereau, Liu (CR16) 1997; 185
AY Lai (BFng3488_CR19) 2013; 23
M Bibikova (BFng3488_CR53) 2009; 1
AE Teschendorff (BFng3488_CR23) 2010; 20
D Lara-Astiaso (BFng3488_CR6) 2014; 345
R Andersson (BFng3488_CR1) 2014; 507
D Sturm (BFng3488_CR36) 2012; 22
Q Wang (BFng3488_CR17) 2013; 8
XS Puente (BFng3488_CR30) 2011; 475
R Desper (BFng3488_CR58) 2002; 9
EN Smith (BFng3488_CR24) 2015; 5
Y Herishanu (BFng3488_CR32) 2011; 117
M Gururajan (BFng3488_CR45) 2008; 181
BFng3488_CR54
LA Garrett-Sinha (BFng3488_CR47) 1999; 10
D Brocks (BFng3488_CR57) 2014; 8
M Seifert (BFng3488_CR28) 2012; 209
A Rosén (BFng3488_CR49) 2010; 20
DA Landau (BFng3488_CR31) 2013; 152
AE Teschendorff (BFng3488_CR55) 2013; 29
A Subramanian (BFng3488_CR59) 2005; 102
CC Oakes (BFng3488_CR13) 2014; 4
AC Queiros (BFng3488_CR11) 2015; 29
U Klein (BFng3488_CR39) 2001; 194
PG Ferreira (BFng3488_CR29) 2014; 24
TH Pham (BFng3488_CR37) 2012; 119
SL Peng (BFng3488_CR46) 2001; 14
J Ernst (BFng3488_CR20) 2011; 473
M Kulis (BFng3488_CR10) 2012; 44
H Li (BFng3488_CR52) 2010; 26
S Lebecque (BFng3488_CR16) 1997; 185
Y Assenov (BFng3488_CR56) 2014; 11
DA Landau (BFng3488_CR14) 2014; 26
J Edelmann (BFng3488_CR35) 2012; 120
CI Mockridge (BFng3488_CR33) 2007; 109
A Kröber (BFng3488_CR51) 2002; 100
L Reindl (BFng3488_CR34) 2010; 151
BFng3488_CR2
LM Heltemes-Harris (BFng3488_CR27) 2011; 208
V Bohle (BFng3488_CR60) 2013; 27
R Claus (BFng3488_CR25) 2014; 124
KH Prange (BFng3488_CR42) 2014; 42
Y Zhuang (BFng3488_CR44) 1994; 79
H Kretzmer (BFng3488_CR43) 2015; 47
M Kasowski (BFng3488_CR5) 2013; 342
MJ Ziller (BFng3488_CR3) 2013; 500
Y Pekarsky (BFng3488_CR50) 2008; 105
H Dvinge (BFng3488_CR21) 2014; 111
L Chen (BFng3488_CR41) 2008; 111
CY McLean (BFng3488_CR61) 2010; 28
N Cabezas-Wallscheid (BFng3488_CR7) 2014; 15
M Kulis (BFng3488_CR15) 2015; 47
S Zandi (BFng3488_CR26) 2008; 181
W Timp (BFng3488_CR9) 2013; 13
R Shaknovich (BFng3488_CR18) 2011; 118
ZD Smith (BFng3488_CR4) 2013; 14
D Schübeler (BFng3488_CR8) 2015; 517
M Gustems (BFng3488_CR48) 2014; 42
U Klein (BFng3488_CR40) 1998; 188
N Cahill (BFng3488_CR12) 2013; 27
C Florean (BFng3488_CR22) 2011; 3
F Damm (BFng3488_CR38) 2014; 4
24071908 - Nat Protoc. 2013 Oct;8(10):2022-32
25103404 - Science. 2014 Aug 22;345(6199):943-9
18048647 - Blood. 2008 Mar 1;111(5):2685-92
20863893 - Semin Cancer Biol. 2010 Dec;20(6):400-9
25158935 - Cell Stem Cell. 2014 Oct 2;15(4):507-22
26437030 - Nat Genet. 2015 Nov;47(11):1316-25
17255355 - Blood. 2007 May 15;109(10):4424-31
24868078 - Blood. 2014 Jul 3;124(1):42-8
12149225 - Blood. 2002 Aug 15;100(4):1410-6
11163226 - Immunity. 2001 Jan;14(1):13-20
25151957 - Leukemia. 2015 Mar;29(3):598-605
9802980 - J Exp Med. 1998 Nov 2;188(9):1679-89
25385641 - Proc Natl Acad Sci U S A. 2014 Nov 25;111(47):16802-7
25262207 - Nat Methods. 2014 Nov;11(11):1138-40
23064414 - Nat Genet. 2012 Nov;44(11):1236-42
22922567 - Leukemia. 2013 Jan;27(1):150-8
20649559 - Br J Haematol. 2010 Oct;151(1):25-36
25860294 - Blood Cancer J. 2015 Apr 10;5:e303
24136358 - Science. 2013 Nov 8;342(6159):750-2
21642962 - Nature. 2011 Jun 05;475(7354):101-5
23175756 - Bioinformatics. 2013 Jan 15;29(2):189-96
23174882 - Leukemia. 2013 Mar;27(3):671-9
23925113 - Nature. 2013 Aug 22;500(7463):477-81
23400093 - Nat Rev Genet. 2013 Mar;14(3):204-20
24920063 - Cancer Discov. 2014 Sep;4(9):1088-101
20219944 - Genome Res. 2010 Apr;20(4):440-6
9053456 - J Exp Med. 1997 Feb 3;185(3):563-71
23760024 - Nat Rev Cancer. 2013 Jul;13(7):497-510
20940416 - Blood. 2011 Jan 13;117(2):563-74
26053498 - Nat Genet. 2015 Jul;47(7):746-56
19064921 - Proc Natl Acad Sci U S A. 2008 Dec 16;105(50):19643-8
16199517 - Proc Natl Acad Sci U S A. 2005 Oct 25;102(43):15545-50
21441907 - Nature. 2011 May 5;473(7345):43-9
23047824 - Blood. 2012 Dec 6;120(24):4783-94
18802061 - J Immunol. 2008 Oct 1;181(7):4590-602
21606506 - J Exp Med. 2011 Jun 6;208(6):1135-49
22550342 - Blood. 2012 Jun 14;119(24):e161-71
22122642 - Epigenomics. 2009 Oct;1(1):177-200
10229183 - Immunity. 1999 Apr;10(4):399-408
21828137 - Blood. 2011 Sep 29;118(13):3559-69
23079654 - Cancer Cell. 2012 Oct 16;22(4):425-37
24371273 - Nucleic Acids Res. 2014 Mar;42(5):3059-72
24356097 - Cancer Discov. 2014 Mar;4(3):348-61
25693563 - Nature. 2015 Feb 19;518(7539):317-30
23415222 - Cell. 2013 Feb 14;152(4):714-26
25066126 - Cell Rep. 2014 Aug 7;8(3):798-806
23091163 - J Exp Med. 2012 Nov 19;209(12):2183-98
24814246 - Exp Hematol. 2014 Aug;42(8):637-50
12487758 - J Comput Biol. 2002;9(5):687-705
24013550 - Genome Res. 2013 Dec;23(12):2030-41
25490447 - Cancer Cell. 2014 Dec 8;26(6):813-25
15499007 - Science. 2004 Oct 22;306(5696):636-40
20436461 - Nat Biotechnol. 2010 May;28(5):495-501
11733577 - J Exp Med. 2001 Dec 3;194(11):1625-38
22126248 - Epigenomics. 2011 Oct;3(5):581-609
25592537 - Nature. 2015 Jan 15;517(7534):321-6
24265505 - Genome Res. 2014 Feb;24(2):212-26
24670763 - Nature. 2014 Mar 27;507(7493):455-61
20080505 - Bioinformatics. 2010 Mar 1;26(5):589-95
18714008 - J Immunol. 2008 Sep 1;181(5):3364-72
8001124 - Cell. 1994 Dec 2;79(5):875-84
References_xml – volume: 194
  start-page: 1625
  year: 2001
  end-page: 1638
  ident: CR39
  article-title: Gene expression profiling of B cell chronic lymphocytic leukemia reveals a homogeneous phenotype related to memory B cells
  publication-title: J. Exp. Med.
  doi: 10.1084/jem.194.11.1625
– volume: 119
  start-page: e161
  year: 2012
  end-page: e171
  ident: CR37
  article-title: Dynamic epigenetic enhancer signatures reveal key transcription factors associated with monocytic differentiation states
  publication-title: Blood
  doi: 10.1182/blood-2012-01-402453
– volume: 117
  start-page: 563
  year: 2011
  end-page: 574
  ident: CR32
  article-title: The lymph node microenvironment promotes B-cell receptor signaling, NF-κB activation, and tumor proliferation in chronic lymphocytic leukemia
  publication-title: Blood
  doi: 10.1182/blood-2010-05-284984
– volume: 8
  start-page: 2022
  year: 2013
  end-page: 2032
  ident: CR17
  article-title: Tagmentation-based whole-genome bisulfite sequencing
  publication-title: Nat. Protoc.
  doi: 10.1038/nprot.2013.118
– volume: 47
  start-page: 1316
  year: 2015
  end-page: 1325
  ident: CR43
  article-title: DNA methylome analysis in Burkitt and follicular lymphomas identifies differentially methylated regions linked to somatic mutation and transcriptional control
  publication-title: Nat. Genet.
  doi: 10.1038/ng.3413
– volume: 9
  start-page: 687
  year: 2002
  end-page: 705
  ident: CR58
  article-title: Fast and accurate phylogeny reconstruction algorithms based on the minimum-evolution principle
  publication-title: J. Comput. Biol.
  doi: 10.1089/106652702761034136
– volume: 100
  start-page: 1410
  year: 2002
  end-page: 1416
  ident: CR51
  article-title: V mutation status, CD38 expression level, genomic aberrations, and survival in chronic lymphocytic leukemia
  publication-title: Blood
  doi: 10.1182/blood.V100.4.1410.h81602001410_1410_1416
– volume: 27
  start-page: 671
  year: 2013
  end-page: 679
  ident: CR60
  article-title: Role of early B-cell factor 1 (EBF1) in Hodgkin lymphoma
  publication-title: Leukemia
  doi: 10.1038/leu.2012.280
– volume: 151
  start-page: 25
  year: 2010
  end-page: 36
  ident: CR34
  article-title: Biological and clinical characterization of recurrent 14q deletions in CLL and other mature B-cell neoplasms
  publication-title: Br. J. Haematol.
  doi: 10.1111/j.1365-2141.2010.08299.x
– ident: CR54
– volume: 473
  start-page: 43
  year: 2011
  end-page: 49
  ident: CR20
  article-title: Mapping and analysis of chromatin state dynamics in nine human cell types
  publication-title: Nature
  doi: 10.1038/nature09906
– volume: 4
  start-page: 348
  year: 2014
  end-page: 361
  ident: CR13
  article-title: Evolution of DNA methylation is linked to genetic aberrations in chronic lymphocytic leukemia
  publication-title: Cancer Discov.
  doi: 10.1158/2159-8290.CD-13-0349
– volume: 124
  start-page: 42
  year: 2014
  end-page: 48
  ident: CR25
  article-title: Validation of ZAP-70 methylation and its relative significance in predicting outcome in chronic lymphocytic leukemia
  publication-title: Blood
  doi: 10.1182/blood-2014-02-555722
– volume: 3
  start-page: 581
  year: 2011
  end-page: 609
  ident: CR22
  article-title: Epigenomics of leukemia: from mechanisms to therapeutic applications
  publication-title: Epigenomics
  doi: 10.2217/epi.11.73
– volume: 13
  start-page: 497
  year: 2013
  end-page: 510
  ident: CR9
  article-title: Cancer as a dysregulated epigenome allowing cellular growth advantage at the expense of the host
  publication-title: Nat. Rev. Cancer
  doi: 10.1038/nrc3486
– volume: 20
  start-page: 400
  year: 2010
  end-page: 409
  ident: CR49
  article-title: Antigens in chronic lymphocytic leukemia—implications for cell origin and leukemogenesis
  publication-title: Semin. Cancer Biol.
  doi: 10.1016/j.semcancer.2010.09.004
– volume: 26
  start-page: 813
  year: 2014
  end-page: 825
  ident: CR14
  article-title: Locally disordered methylation forms the basis of intratumor methylome variation in chronic lymphocytic leukemia
  publication-title: Cancer Cell
  doi: 10.1016/j.ccell.2014.10.012
– volume: 118
  start-page: 3559
  year: 2011
  end-page: 3569
  ident: CR18
  article-title: DNA methyltransferase 1 and DNA methylation patterning contribute to germinal center B-cell differentiation
  publication-title: Blood
  doi: 10.1182/blood-2011-06-357996
– volume: 11
  start-page: 1138
  year: 2014
  end-page: 1140
  ident: CR56
  article-title: Comprehensive analysis of DNA methylation data with RnBeads
  publication-title: Nat. Methods
  doi: 10.1038/nmeth.3115
– volume: 8
  start-page: 798
  year: 2014
  end-page: 806
  ident: CR57
  article-title: Epigenetic intratumor heterogeneity and clonal evolution in aggressive prostate cancer
  publication-title: Cell Rep.
  doi: 10.1016/j.celrep.2014.06.053
– volume: 102
  start-page: 15545
  year: 2005
  end-page: 15550
  ident: CR59
  article-title: Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles
  publication-title: Proc. Natl. Acad. Sci. USA
– volume: 342
  start-page: 750
  year: 2013
  end-page: 752
  ident: CR5
  article-title: Extensive variation in chromatin states across humans
  publication-title: Science
  doi: 10.1126/science.1242510
– volume: 44
  start-page: 1236
  year: 2012
  end-page: 1242
  ident: CR10
  article-title: Epigenomic analysis detects widespread gene-body DNA hypomethylation in chronic lymphocytic leukemia
  publication-title: Nat. Genet.
  doi: 10.1038/ng.2443
– volume: 105
  start-page: 19643
  year: 2008
  end-page: 19648
  ident: CR50
  article-title: Tcl1 functions as a transcriptional regulator and is directly involved in the pathogenesis of CLL
  publication-title: Proc. Natl. Acad. Sci. USA
  doi: 10.1073/pnas.0810965105
– volume: 475
  start-page: 101
  year: 2011
  end-page: 105
  ident: CR30
  article-title: Whole-genome sequencing identifies recurrent mutations in chronic lymphocytic leukaemia
  publication-title: Nature
  doi: 10.1038/nature10113
– volume: 517
  start-page: 321
  year: 2015
  end-page: 326
  ident: CR8
  article-title: Function and information content of DNA methylation
  publication-title: Nature
  doi: 10.1038/nature14192
– volume: 20
  start-page: 440
  year: 2010
  end-page: 446
  ident: CR23
  article-title: Age-dependent DNA methylation of genes that are suppressed in stem cells is a hallmark of cancer
  publication-title: Genome Res.
  doi: 10.1101/gr.103606.109
– volume: 181
  start-page: 3364
  year: 2008
  end-page: 3372
  ident: CR26
  article-title: EBF1 is essential for B-lineage priming and establishment of a transcription factor network in common lymphoid progenitors
  publication-title: J. Immunol.
  doi: 10.4049/jimmunol.181.5.3364
– volume: 5
  start-page: e303
  year: 2015
  ident: CR24
  article-title: Genetic and epigenetic profiling of CLL disease progression reveals limited somatic evolution and suggests a relationship to memory-cell development
  publication-title: Blood Cancer J.
  doi: 10.1038/bcj.2015.14
– volume: 79
  start-page: 875
  year: 1994
  end-page: 884
  ident: CR44
  article-title: The helix-loop-helix gene is required for B cell formation
  publication-title: Cell
  doi: 10.1016/0092-8674(94)90076-0
– volume: 15
  start-page: 507
  year: 2014
  end-page: 522
  ident: CR7
  article-title: Identification of regulatory networks in HSCs and their immediate progeny via integrated proteome, transcriptome, and DNA methylome analysis
  publication-title: Cell Stem Cell
  doi: 10.1016/j.stem.2014.07.005
– volume: 188
  start-page: 1679
  year: 1998
  end-page: 1689
  ident: CR40
  article-title: Human immunoglobulin (Ig)M IgD peripheral blood B cells expressing the CD27 cell surface antigen carry somatically mutated variable region genes: CD27 as a general marker for somatically mutated (memory) B cells
  publication-title: J. Exp. Med.
  doi: 10.1084/jem.188.9.1679
– volume: 109
  start-page: 4424
  year: 2007
  end-page: 4431
  ident: CR33
  article-title: Reversible anergy of sIgM-mediated signaling in the two subsets of CLL defined by V -gene mutational status
  publication-title: Blood
  doi: 10.1182/blood-2006-11-056648
– volume: 26
  start-page: 589
  year: 2010
  end-page: 595
  ident: CR52
  article-title: Fast and accurate long-read alignment with Burrows-Wheeler transform
  publication-title: Bioinformatics
  doi: 10.1093/bioinformatics/btp698
– volume: 208
  start-page: 1135
  year: 2011
  end-page: 1149
  ident: CR27
  article-title: Ebf1 or Pax5 haploinsufficiency synergizes with STAT5 activation to initiate acute lymphoblastic leukemia
  publication-title: J. Exp. Med.
  doi: 10.1084/jem.20101947
– ident: CR2
– volume: 28
  start-page: 495
  year: 2010
  end-page: 501
  ident: CR61
  article-title: GREAT improves functional interpretation of -regulatory regions
  publication-title: Nat. Biotechnol.
  doi: 10.1038/nbt.1630
– volume: 500
  start-page: 477
  year: 2013
  end-page: 481
  ident: CR3
  article-title: Charting a dynamic DNA methylation landscape of the human genome
  publication-title: Nature
  doi: 10.1038/nature12433
– volume: 14
  start-page: 13
  year: 2001
  end-page: 20
  ident: CR46
  article-title: NFATc1 and NFATc2 together control both T and B cell activation and differentiation
  publication-title: Immunity
  doi: 10.1016/S1074-7613(01)00085-1
– volume: 209
  start-page: 2183
  year: 2012
  end-page: 2198
  ident: CR28
  article-title: Cellular origin and pathophysiology of chronic lymphocytic leukemia
  publication-title: J. Exp. Med.
  doi: 10.1084/jem.20120833
– volume: 42
  start-page: 3059
  year: 2014
  end-page: 3072
  ident: CR48
  article-title: c-Jun/c-Fos heterodimers regulate cellular genes via a newly identified class of methylated DNA sequence motifs
  publication-title: Nucleic Acids Res.
  doi: 10.1093/nar/gkt1323
– volume: 120
  start-page: 4783
  year: 2012
  end-page: 4794
  ident: CR35
  article-title: High-resolution genomic profiling of chronic lymphocytic leukemia reveals new recurrent genomic alterations
  publication-title: Blood
  doi: 10.1182/blood-2012-04-423517
– volume: 4
  start-page: 1088
  year: 2014
  end-page: 1101
  ident: CR38
  article-title: Acquired initiating mutations in early hematopoietic cells of CLL patients
  publication-title: Cancer Discov.
  doi: 10.1158/2159-8290.CD-14-0104
– volume: 111
  start-page: 2685
  year: 2008
  end-page: 2692
  ident: CR41
  article-title: ZAP-70 enhances IgM signaling independent of its kinase activity in chronic lymphocytic leukemia
  publication-title: Blood
  doi: 10.1182/blood-2006-12-062265
– volume: 10
  start-page: 399
  year: 1999
  end-page: 408
  ident: CR47
  article-title: PU.1 and Spi-B are required for normal B cell receptor–mediated signal transduction
  publication-title: Immunity
  doi: 10.1016/S1074-7613(00)80040-0
– volume: 185
  start-page: 563
  year: 1997
  end-page: 571
  ident: CR16
  article-title: Germinal center founder cells display propensity for apoptosis before onset of somatic mutation
  publication-title: J. Exp. Med.
  doi: 10.1084/jem.185.3.563
– volume: 22
  start-page: 425
  year: 2012
  end-page: 437
  ident: CR36
  article-title: Hotspot mutations in and define distinct epigenetic and biological subgroups of glioblastoma
  publication-title: Cancer Cell
  doi: 10.1016/j.ccr.2012.08.024
– volume: 23
  start-page: 2030
  year: 2013
  end-page: 2041
  ident: CR19
  article-title: DNA methylation profiling in human B cells reveals immune regulatory elements and epigenetic plasticity at Alu elements during B-cell activation
  publication-title: Genome Res.
  doi: 10.1101/gr.155473.113
– volume: 29
  start-page: 598
  year: 2015
  end-page: 605
  ident: CR11
  article-title: A B-cell epigenetic signature defines three biologic subgroups of chronic lymphocytic leukemia with clinical impact
  publication-title: Leukemia
  doi: 10.1038/leu.2014.252
– volume: 181
  start-page: 4590
  year: 2008
  end-page: 4602
  ident: CR45
  article-title: Early growth response genes regulate B cell development, proliferation, and immune response
  publication-title: J. Immunol.
  doi: 10.4049/jimmunol.181.7.4590
– volume: 507
  start-page: 455
  year: 2014
  end-page: 461
  ident: CR1
  article-title: An atlas of active enhancers across human cell types and tissues
  publication-title: Nature
  doi: 10.1038/nature12787
– volume: 345
  start-page: 943
  year: 2014
  end-page: 949
  ident: CR6
  article-title: Chromatin state dynamics during blood formation
  publication-title: Science
  doi: 10.1126/science.1256271
– volume: 42
  start-page: 637
  year: 2014
  end-page: 650
  ident: CR42
  article-title: The genome-wide molecular signature of transcription factors in leukemia
  publication-title: Exp. Hematol.
  doi: 10.1016/j.exphem.2014.04.012
– volume: 152
  start-page: 714
  year: 2013
  end-page: 726
  ident: CR31
  article-title: Evolution and impact of subclonal mutations in chronic lymphocytic leukemia
  publication-title: Cell
  doi: 10.1016/j.cell.2013.01.019
– volume: 24
  start-page: 212
  year: 2014
  end-page: 226
  ident: CR29
  article-title: Transcriptome characterization by RNA sequencing identifies a major molecular and clinical subdivision in chronic lymphocytic leukemia
  publication-title: Genome Res.
  doi: 10.1101/gr.152132.112
– volume: 1
  start-page: 177
  year: 2009
  end-page: 200
  ident: CR53
  article-title: Genome-wide DNA methylation profiling using Infinium assay
  publication-title: Epigenomics
  doi: 10.2217/epi.09.14
– volume: 111
  start-page: 16802
  year: 2014
  end-page: 16807
  ident: CR21
  article-title: Sample processing obscures cancer-specific alterations in leukemic transcriptomes
  publication-title: Proc. Natl. Acad. Sci. USA
  doi: 10.1073/pnas.1413374111
– volume: 14
  start-page: 204
  year: 2013
  end-page: 220
  ident: CR4
  article-title: DNA methylation: roles in mammalian development
  publication-title: Nat. Rev. Genet.
– volume: 27
  start-page: 150
  year: 2013
  end-page: 158
  ident: CR12
  article-title: 450K-array analysis of chronic lymphocytic leukemia cells reveals global DNA methylation to be relatively stable over time and similar in resting and proliferative compartments
  publication-title: Leukemia
  doi: 10.1038/leu.2012.245
– volume: 47
  start-page: 746
  year: 2015
  end-page: 756
  ident: CR15
  article-title: Whole-genome fingerprint of the DNA methylome during human B cell differentiation
  publication-title: Nat. Genet.
  doi: 10.1038/ng.3291
– volume: 29
  start-page: 189
  year: 2013
  end-page: 196
  ident: CR55
  article-title: A beta-mixture quantile normalization method for correcting probe design bias in Illumina Infinium 450 k DNA methylation data
  publication-title: Bioinformatics
  doi: 10.1093/bioinformatics/bts680
– volume: 29
  start-page: 598
  year: 2015
  ident: BFng3488_CR11
  publication-title: Leukemia
  doi: 10.1038/leu.2014.252
– volume: 188
  start-page: 1679
  year: 1998
  ident: BFng3488_CR40
  publication-title: J. Exp. Med.
  doi: 10.1084/jem.188.9.1679
– volume: 475
  start-page: 101
  year: 2011
  ident: BFng3488_CR30
  publication-title: Nature
  doi: 10.1038/nature10113
– volume: 111
  start-page: 2685
  year: 2008
  ident: BFng3488_CR41
  publication-title: Blood
  doi: 10.1182/blood-2006-12-062265
– volume: 9
  start-page: 687
  year: 2002
  ident: BFng3488_CR58
  publication-title: J. Comput. Biol.
  doi: 10.1089/106652702761034136
– volume: 102
  start-page: 15545
  year: 2005
  ident: BFng3488_CR59
  publication-title: Proc. Natl. Acad. Sci. USA
  doi: 10.1073/pnas.0506580102
– volume: 15
  start-page: 507
  year: 2014
  ident: BFng3488_CR7
  publication-title: Cell Stem Cell
  doi: 10.1016/j.stem.2014.07.005
– volume: 473
  start-page: 43
  year: 2011
  ident: BFng3488_CR20
  publication-title: Nature
  doi: 10.1038/nature09906
– volume: 27
  start-page: 671
  year: 2013
  ident: BFng3488_CR60
  publication-title: Leukemia
  doi: 10.1038/leu.2012.280
– volume: 13
  start-page: 497
  year: 2013
  ident: BFng3488_CR9
  publication-title: Nat. Rev. Cancer
  doi: 10.1038/nrc3486
– volume: 4
  start-page: 1088
  year: 2014
  ident: BFng3488_CR38
  publication-title: Cancer Discov.
  doi: 10.1158/2159-8290.CD-14-0104
– volume: 5
  start-page: e303
  year: 2015
  ident: BFng3488_CR24
  publication-title: Blood Cancer J.
  doi: 10.1038/bcj.2015.14
– volume: 42
  start-page: 637
  year: 2014
  ident: BFng3488_CR42
  publication-title: Exp. Hematol.
  doi: 10.1016/j.exphem.2014.04.012
– volume: 20
  start-page: 400
  year: 2010
  ident: BFng3488_CR49
  publication-title: Semin. Cancer Biol.
  doi: 10.1016/j.semcancer.2010.09.004
– volume: 23
  start-page: 2030
  year: 2013
  ident: BFng3488_CR19
  publication-title: Genome Res.
  doi: 10.1101/gr.155473.113
– volume: 42
  start-page: 3059
  year: 2014
  ident: BFng3488_CR48
  publication-title: Nucleic Acids Res.
  doi: 10.1093/nar/gkt1323
– volume: 500
  start-page: 477
  year: 2013
  ident: BFng3488_CR3
  publication-title: Nature
  doi: 10.1038/nature12433
– volume: 117
  start-page: 563
  year: 2011
  ident: BFng3488_CR32
  publication-title: Blood
  doi: 10.1182/blood-2010-05-284984
– volume: 8
  start-page: 2022
  year: 2013
  ident: BFng3488_CR17
  publication-title: Nat. Protoc.
  doi: 10.1038/nprot.2013.118
– volume: 27
  start-page: 150
  year: 2013
  ident: BFng3488_CR12
  publication-title: Leukemia
  doi: 10.1038/leu.2012.245
– volume: 24
  start-page: 212
  year: 2014
  ident: BFng3488_CR29
  publication-title: Genome Res.
  doi: 10.1101/gr.152132.112
– volume: 47
  start-page: 1316
  year: 2015
  ident: BFng3488_CR43
  publication-title: Nat. Genet.
  doi: 10.1038/ng.3413
– volume: 29
  start-page: 189
  year: 2013
  ident: BFng3488_CR55
  publication-title: Bioinformatics
  doi: 10.1093/bioinformatics/bts680
– volume: 120
  start-page: 4783
  year: 2012
  ident: BFng3488_CR35
  publication-title: Blood
  doi: 10.1182/blood-2012-04-423517
– volume: 181
  start-page: 4590
  year: 2008
  ident: BFng3488_CR45
  publication-title: J. Immunol.
  doi: 10.4049/jimmunol.181.7.4590
– volume: 185
  start-page: 563
  year: 1997
  ident: BFng3488_CR16
  publication-title: J. Exp. Med.
  doi: 10.1084/jem.185.3.563
– volume: 3
  start-page: 581
  year: 2011
  ident: BFng3488_CR22
  publication-title: Epigenomics
  doi: 10.2217/epi.11.73
– volume: 8
  start-page: 798
  year: 2014
  ident: BFng3488_CR57
  publication-title: Cell Rep.
  doi: 10.1016/j.celrep.2014.06.053
– ident: BFng3488_CR54
  doi: 10.1126/science.1105136
– volume: 345
  start-page: 943
  year: 2014
  ident: BFng3488_CR6
  publication-title: Science
  doi: 10.1126/science.1256271
– volume: 209
  start-page: 2183
  year: 2012
  ident: BFng3488_CR28
  publication-title: J. Exp. Med.
  doi: 10.1084/jem.20120833
– ident: BFng3488_CR2
– volume: 26
  start-page: 589
  year: 2010
  ident: BFng3488_CR52
  publication-title: Bioinformatics
  doi: 10.1093/bioinformatics/btp698
– volume: 181
  start-page: 3364
  year: 2008
  ident: BFng3488_CR26
  publication-title: J. Immunol.
  doi: 10.4049/jimmunol.181.5.3364
– volume: 22
  start-page: 425
  year: 2012
  ident: BFng3488_CR36
  publication-title: Cancer Cell
  doi: 10.1016/j.ccr.2012.08.024
– volume: 111
  start-page: 16802
  year: 2014
  ident: BFng3488_CR21
  publication-title: Proc. Natl. Acad. Sci. USA
  doi: 10.1073/pnas.1413374111
– volume: 507
  start-page: 455
  year: 2014
  ident: BFng3488_CR1
  publication-title: Nature
  doi: 10.1038/nature12787
– volume: 10
  start-page: 399
  year: 1999
  ident: BFng3488_CR47
  publication-title: Immunity
  doi: 10.1016/S1074-7613(00)80040-0
– volume: 342
  start-page: 750
  year: 2013
  ident: BFng3488_CR5
  publication-title: Science
  doi: 10.1126/science.1242510
– volume: 47
  start-page: 746
  year: 2015
  ident: BFng3488_CR15
  publication-title: Nat. Genet.
  doi: 10.1038/ng.3291
– volume: 20
  start-page: 440
  year: 2010
  ident: BFng3488_CR23
  publication-title: Genome Res.
  doi: 10.1101/gr.103606.109
– volume: 517
  start-page: 321
  year: 2015
  ident: BFng3488_CR8
  publication-title: Nature
  doi: 10.1038/nature14192
– volume: 44
  start-page: 1236
  year: 2012
  ident: BFng3488_CR10
  publication-title: Nat. Genet.
  doi: 10.1038/ng.2443
– volume: 118
  start-page: 3559
  year: 2011
  ident: BFng3488_CR18
  publication-title: Blood
  doi: 10.1182/blood-2011-06-357996
– volume: 124
  start-page: 42
  year: 2014
  ident: BFng3488_CR25
  publication-title: Blood
  doi: 10.1182/blood-2014-02-555722
– volume: 105
  start-page: 19643
  year: 2008
  ident: BFng3488_CR50
  publication-title: Proc. Natl. Acad. Sci. USA
  doi: 10.1073/pnas.0810965105
– volume: 1
  start-page: 177
  year: 2009
  ident: BFng3488_CR53
  publication-title: Epigenomics
  doi: 10.2217/epi.09.14
– volume: 11
  start-page: 1138
  year: 2014
  ident: BFng3488_CR56
  publication-title: Nat. Methods
  doi: 10.1038/nmeth.3115
– volume: 28
  start-page: 495
  year: 2010
  ident: BFng3488_CR61
  publication-title: Nat. Biotechnol.
  doi: 10.1038/nbt.1630
– volume: 4
  start-page: 348
  year: 2014
  ident: BFng3488_CR13
  publication-title: Cancer Discov.
  doi: 10.1158/2159-8290.CD-13-0349
– volume: 208
  start-page: 1135
  year: 2011
  ident: BFng3488_CR27
  publication-title: J. Exp. Med.
  doi: 10.1084/jem.20101947
– volume: 194
  start-page: 1625
  year: 2001
  ident: BFng3488_CR39
  publication-title: J. Exp. Med.
  doi: 10.1084/jem.194.11.1625
– volume: 79
  start-page: 875
  year: 1994
  ident: BFng3488_CR44
  publication-title: Cell
  doi: 10.1016/0092-8674(94)90076-0
– volume: 119
  start-page: e161
  year: 2012
  ident: BFng3488_CR37
  publication-title: Blood
  doi: 10.1182/blood-2012-01-402453
– volume: 100
  start-page: 1410
  year: 2002
  ident: BFng3488_CR51
  publication-title: Blood
  doi: 10.1182/blood.V100.4.1410.h81602001410_1410_1416
– volume: 109
  start-page: 4424
  year: 2007
  ident: BFng3488_CR33
  publication-title: Blood
  doi: 10.1182/blood-2006-11-056648
– volume: 26
  start-page: 813
  year: 2014
  ident: BFng3488_CR14
  publication-title: Cancer Cell
  doi: 10.1016/j.ccell.2014.10.012
– volume: 152
  start-page: 714
  year: 2013
  ident: BFng3488_CR31
  publication-title: Cell
  doi: 10.1016/j.cell.2013.01.019
– volume: 14
  start-page: 204
  year: 2013
  ident: BFng3488_CR4
  publication-title: Nat. Rev. Genet.
  doi: 10.1038/nrg3354
– volume: 151
  start-page: 25
  year: 2010
  ident: BFng3488_CR34
  publication-title: Br. J. Haematol.
  doi: 10.1111/j.1365-2141.2010.08299.x
– volume: 14
  start-page: 13
  year: 2001
  ident: BFng3488_CR46
  publication-title: Immunity
  doi: 10.1016/S1074-7613(01)00085-1
– reference: 11733577 - J Exp Med. 2001 Dec 3;194(11):1625-38
– reference: 24670763 - Nature. 2014 Mar 27;507(7493):455-61
– reference: 20080505 - Bioinformatics. 2010 Mar 1;26(5):589-95
– reference: 23174882 - Leukemia. 2013 Mar;27(3):671-9
– reference: 18714008 - J Immunol. 2008 Sep 1;181(5):3364-72
– reference: 20863893 - Semin Cancer Biol. 2010 Dec;20(6):400-9
– reference: 21606506 - J Exp Med. 2011 Jun 6;208(6):1135-49
– reference: 12149225 - Blood. 2002 Aug 15;100(4):1410-6
– reference: 8001124 - Cell. 1994 Dec 2;79(5):875-84
– reference: 10229183 - Immunity. 1999 Apr;10(4):399-408
– reference: 23064414 - Nat Genet. 2012 Nov;44(11):1236-42
– reference: 21441907 - Nature. 2011 May 5;473(7345):43-9
– reference: 22550342 - Blood. 2012 Jun 14;119(24):e161-71
– reference: 21642962 - Nature. 2011 Jun 05;475(7354):101-5
– reference: 25151957 - Leukemia. 2015 Mar;29(3):598-605
– reference: 24136358 - Science. 2013 Nov 8;342(6159):750-2
– reference: 26053498 - Nat Genet. 2015 Jul;47(7):746-56
– reference: 15499007 - Science. 2004 Oct 22;306(5696):636-40
– reference: 24013550 - Genome Res. 2013 Dec;23(12):2030-41
– reference: 23415222 - Cell. 2013 Feb 14;152(4):714-26
– reference: 24071908 - Nat Protoc. 2013 Oct;8(10):2022-32
– reference: 25592537 - Nature. 2015 Jan 15;517(7534):321-6
– reference: 23091163 - J Exp Med. 2012 Nov 19;209(12):2183-98
– reference: 25490447 - Cancer Cell. 2014 Dec 8;26(6):813-25
– reference: 25262207 - Nat Methods. 2014 Nov;11(11):1138-40
– reference: 9053456 - J Exp Med. 1997 Feb 3;185(3):563-71
– reference: 26437030 - Nat Genet. 2015 Nov;47(11):1316-25
– reference: 22922567 - Leukemia. 2013 Jan;27(1):150-8
– reference: 25693563 - Nature. 2015 Feb 19;518(7539):317-30
– reference: 23760024 - Nat Rev Cancer. 2013 Jul;13(7):497-510
– reference: 23175756 - Bioinformatics. 2013 Jan 15;29(2):189-96
– reference: 24371273 - Nucleic Acids Res. 2014 Mar;42(5):3059-72
– reference: 25103404 - Science. 2014 Aug 22;345(6199):943-9
– reference: 21828137 - Blood. 2011 Sep 29;118(13):3559-69
– reference: 19064921 - Proc Natl Acad Sci U S A. 2008 Dec 16;105(50):19643-8
– reference: 20436461 - Nat Biotechnol. 2010 May;28(5):495-501
– reference: 25860294 - Blood Cancer J. 2015 Apr 10;5:e303
– reference: 12487758 - J Comput Biol. 2002;9(5):687-705
– reference: 24920063 - Cancer Discov. 2014 Sep;4(9):1088-101
– reference: 20940416 - Blood. 2011 Jan 13;117(2):563-74
– reference: 22126248 - Epigenomics. 2011 Oct;3(5):581-609
– reference: 24868078 - Blood. 2014 Jul 3;124(1):42-8
– reference: 22122642 - Epigenomics. 2009 Oct;1(1):177-200
– reference: 23400093 - Nat Rev Genet. 2013 Mar;14(3):204-20
– reference: 25385641 - Proc Natl Acad Sci U S A. 2014 Nov 25;111(47):16802-7
– reference: 24265505 - Genome Res. 2014 Feb;24(2):212-26
– reference: 25066126 - Cell Rep. 2014 Aug 7;8(3):798-806
– reference: 24814246 - Exp Hematol. 2014 Aug;42(8):637-50
– reference: 23047824 - Blood. 2012 Dec 6;120(24):4783-94
– reference: 18802061 - J Immunol. 2008 Oct 1;181(7):4590-602
– reference: 17255355 - Blood. 2007 May 15;109(10):4424-31
– reference: 20649559 - Br J Haematol. 2010 Oct;151(1):25-36
– reference: 24356097 - Cancer Discov. 2014 Mar;4(3):348-61
– reference: 23079654 - Cancer Cell. 2012 Oct 16;22(4):425-37
– reference: 25158935 - Cell Stem Cell. 2014 Oct 2;15(4):507-22
– reference: 23925113 - Nature. 2013 Aug 22;500(7463):477-81
– reference: 11163226 - Immunity. 2001 Jan;14(1):13-20
– reference: 20219944 - Genome Res. 2010 Apr;20(4):440-6
– reference: 9802980 - J Exp Med. 1998 Nov 2;188(9):1679-89
– reference: 16199517 - Proc Natl Acad Sci U S A. 2005 Oct 25;102(43):15545-50
– reference: 18048647 - Blood. 2008 Mar 1;111(5):2685-92
SSID ssj0014408
Score 2.6013083
Snippet Christoph Plass, Christopher Oakes and colleagues study genome-wide DNA methylation dynamics during B cell maturation and the pathogenic role of transcription...
Charting differences between tumors and normal tissue is a mainstay of cancer research. However, clonal tumor expansion from complex normal tissue...
SourceID pubmedcentral
proquest
gale
pubmed
crossref
springer
SourceType Open Access Repository
Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 253
SubjectTerms 13/1
13/106
38/91
45/22
45/23
45/90
631/208/177
692/699/67/1990/283/1895
Adult
Aged
Aged, 80 and over
Agriculture
Animal Genetics and Genomics
B cells
B-Lymphocytes - immunology
B-Lymphocytes - metabolism
Binding Sites
Biomedicine
Cancer
Cancer Research
Chronic lymphocytic leukemia
Consortia
CpG Islands - genetics
Deoxyribonucleic acid
Development and progression
Developmental stages
DNA
DNA methylation
DNA Methylation - genetics
Epigenesis, Genetic
Epigenetic inheritance
Epigenetics
Female
Gene expression
Gene Expression Regulation, Leukemic
Gene Expression Regulation, Neoplastic
Gene Function
Genetic aspects
Genomes
Growth
Health aspects
Human Genetics
Humans
Leukemia
Leukemia, Lymphocytic, Chronic, B-Cell - genetics
Leukemia, Lymphocytic, Chronic, B-Cell - immunology
Leukemia, Lymphocytic, Chronic, B-Cell - pathology
Male
Medical research
Middle Aged
Neoplasm Proteins - biosynthesis
Neoplasm Proteins - genetics
Phenotype
Promoter Regions, Genetic
Software
Transcription factors
Tumors
Title DNA methylation dynamics during B cell maturation underlie a continuum of disease phenotypes in chronic lymphocytic leukemia
URI https://link.springer.com/article/10.1038/ng.3488
https://www.ncbi.nlm.nih.gov/pubmed/26780610
https://www.proquest.com/docview/1770389453
https://www.proquest.com/docview/1768167104
https://www.proquest.com/docview/1808740193
https://pubmed.ncbi.nlm.nih.gov/PMC4963005
Volume 48
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3db9MwELdgExIvE98UxmQQgqewpLaT9Al1Y9NAoqDBUN8sf6VUrM5YmodK_PHcxWm2FLGXqJKvrWPf2Wff3e9HyGvhtLWiYJHWwkQ81XGk8iGPnDaCazAuJbDe-fMkPTnjn6Zi2l64VW1a5XpNbBZqWxq8I99Psgyx4Lhg7y9-R8gahdHVlkLjNtlG6DLU6mzaHbgwbhlK4VI8J2GYcieUmef7fvaO8YZu5Wo32lyTr21KmwmTG1HTZjM6vkd2Wi-SjsO03ye3nH9A7gReydVD8ufDZEyRG3oVMt2oDbzzFQ1VifSA4oU9XSCqZ5DAWrJL8Eepopi9Pvd1vaBlQdsADsVUsBLvays699QESF16vgJlKM1qiZ9d_cst5uoROTs--n54ErU0C5HJGF_CUylRDDWyonObMG0SmCgTK1uwQucu04opZsUo5laAdwibHku4yOLUgLm7EXtMtnzp3VNCc66R1MqCVTPuMoXQNHEaG2USllrNB-TNerilaTHIkQrjXDaxcJZLP5M4LwNCO8GLALvxr8grnC-JIBYes2Rmqq4q-fHLDzmGMy6cXMFZ-p_Qt9Oe0NtWqCihN9DbUJkA74TgWD3J3Z4kmKLpN691R7ZLQSWvFHdAXnbN-E1Mb_OurFEmzZMUnD1-g0weN_SJI_idJ0Edu6EZgssBSh4PSNZT1E4AQcT7LX7-swET5yMEXRPwv2uVvtb1_og_u_n1npO74E2mIUFvl2wtL2v3Ajy2pd5rzBKe-WGyR7YPjiZfT_8CgdVEBw
linkProvider ProQuest
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3db9MwELemIQQvE990DDCIj6ewJLaT9AGhsjG1bCsSbNPegu04pdqajKURisTfxN_IXZx0SxF720sVyb-kjn0-n3N3vyPklTAqSUTKHKWEdnigXEdGPneM0oIrWFxSYL7z_jgYHvLPx-J4hfxpc2EwrLLVibWiTnKN38g3vTBELjgu2Ieznw5WjULvaltCw4rFrql-wZGteD_ahvl97fs7nw62hk5TVcDRIeNz-JVSpL7CIuA88ZjSHvRLuzJJWaoiEyrJJEtE3-WJAGMIdDzzuAjdQIN0GyRfApV_gzNYmpiZvrUIKUE_qU29C_Bchm7RNZvWHm1mk3eM1-VdLna_5T3g0ia4HKC55KWtN7-dO2StsVrpwIrZXbJisnvkpq1jWd0nv7fHA4q1qCsbWUcTW-e-oDYLkn6k6CCgM2QRtQjMXTsH-5dKitHy06wsZzRPaeMwohh6luP34YJOM6othS89rUD4cl3N8dqUJ2Y2lQ_I4bVMwEOymuWZeUxoxBUW0UpAizBuQolUOG7gaqk9FiSK98ibdrhj3XCeY-mN07j2vbMoziYxzkuP0AXwzNJ8_At5ifMVI2lGhlE5E1kWRTz6chQP4EwNJ2Uwzv4H-va1A3rbgNIcegO9tZkQ8E5IxtVBbnSQsPR1t7mVnbhRPUV8sVB65MWiGe_EcLrM5CVigsgLwLjkV2Aity7X2IfnPLLiuBgaH0wcEHK3R8KOoC4ASFrebcmmP2ryct5HkjcB_9uK9KWud0d8_erXe05uDQ_29-K90Xj3CbkNlmxggwM3yOr8vDRPwVqcq2f1EqXk-3XrhL9a2X3n
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3db9MwELemIRAvE98UBhjEx1NoEttJ-oBQWalWBgUBm_YWbMcpFWsylkaoEn8Zfx13cZItRextL1UkX1LHPp_Pubvfj5CnwqgkESlzlBLa4YFyHRn53DFKC65gcUmB9c4fpsHuPn93KA43yJ-mFgbTKhubWBnqJNf4jbzvhSFiwXHB-mmdFvFpNH59_NNBBimMtDZ0GlZF9szqFxzfileTEcz1M98fv_26s-vUDAOODhlfwq-UIvUVEoLzxGNKe9BH7cokZamKTKgkkywRA5cnAhwjsPfM4yJ0Aw2abhCICcz_pZCFEa6xaKdNL8GYqS3DC_CMhiHSLVviHvWz2UvGK6qX051wfT84syGuJ2uuRWyrjXB8jWzVHiwdWpW7TjZMdoNctpyWq5vk92g6pMhLvbJZdjSxnPcFtRWR9A3FYAFdIKKolcA6thPwhamkmDk_z8pyQfOU1sEjimloOX4rLug8o9rC-dKjFShirldLvDblD7OYy1tk_0Im4DbZzPLM3CU04goJtRKwKIybUCIsjhu4WmqPBYniPfK8Ge5Y1_jnSMNxFFdxeBbF2SzGeekR2goeW8iPf0We4HzFCKCRoSrOZFkU8eTjQTyE8zWcmsFR-5_Ql88doRe1UJpDb6C3tioC3gmBuTqS2x1JMAO629zoTlyboSI-XTQ98rhtxjsxtS4zeYkyQeQF4Gjyc2Qit6JuHMBz7lh1bIfGB3cHlNztkbCjqK0AAph3W7L59wrInA8Q8E3A_zYqfabr3RG_d_7rPSJXwBrE7yfTvfvkKji1gc0T3Caby5PSPADHcakeViuUkm8XbRL-AjfWgh0
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=DNA+methylation+dynamics+during+B+cell+maturation+underlie+a+continuum+of+disease+phenotypes+in+chronic+lymphocytic+leukemia&rft.jtitle=Nature+genetics&rft.au=Oakes%2C+Christopher+C&rft.au=Seifert%2C+Marc&rft.au=Assenov%2C+Yassen&rft.au=Gu%2C+Lei&rft.date=2016-03-01&rft.pub=Nature+Publishing+Group&rft.issn=1061-4036&rft.eissn=1546-1718&rft.volume=48&rft.issue=3&rft.spage=253&rft_id=info:doi/10.1038%2Fng.3488&rft.externalDBID=HAS_PDF_LINK&rft.externalDocID=3970892311
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1061-4036&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1061-4036&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1061-4036&client=summon